Inorganic Chemistry
Article
assignments and spectra of pure RS/SR isomer are included in the
Supporting Information. Colorless crystals suitable for X-ray
diffraction were obtained as blocks by slow evaporation of a 1:1
CH2Cl2/CH3OH solution of PTA-CH(p-C6H4OCH3)NHPh (RS/SR
enantiomers) over the course of a few days.
(s, C6H5CH3), 80.22 (d, JPC = 5 Hz, PCHCHN), 79.82 (s, C6H5CH3),
3
3
75.12 (d, JPC = 5 Hz, NCH2N), 72.64 (d, JPC = 8 Hz, NCH2N),
3
65.88 (d, JPC = 8 Hz, NCH2N), 65.47 (d, JPC = 8 Hz, C6H5CH3),
64.14 (d, JPC = 21 Hz, PCHC), 51.66−51.44 (m, PCH2N), 50.68 (d,
1JPC = 15 Hz, PCH2N), 17.63 (s, C6H5CH3). 31P{1H} NMR (162
Synthesis of PTA-CPh2NHPh (3). A suspension of PTA-Li (1.64
g, 10.0 mmol) in THF (40 mL) was cooled to −78 °C, and a THF
solution (20 mL) of N-(diphenylmethylene)aniline (2.60 g, 10.1
mmol) was added via cannula. The resulting mixture was kept at −78
°C for 30 min, after which the solution was slowly warmed to room
temperature. After stirring for 1 h, an orange homogeneous solution
formed. Following 2 h of stirring, distilled water (3 mL) was added to
quench to the reaction, and the solvent was removed under reduced
pressure. The resulting residue was dissolved in water (30 mL) and
extracted with dichloromethane (40 mL × 4). The combined organic
layers were dried with anhydrous potassium carbonate, filtered
through Celite, and evaporated to dryness under reduced pressure
to give a yellow oil. The yellow oily crude product was taken up into
THF (10 mL), followed by adding hexanes (120 mL) under nitrogen.
After being placed in the freezer for 1 h, this mixture was filtered,
washed with hexane (10 mL × 3), and dried in vacuo to afford the
desired product as a pale yellow crystalline powder (3.18 g, 77% yield).
1H NMR (400 MHz, CDCl3): δ 7.85 (d, JHH = 8.0 Hz, 2H, Ar), 7.77
(d, JHH = 7.2 Hz, 2H, Ar), 7.45−7.38 (m, 3H, Ar), 7.33−7.29 (m, 2H,
Ar), 7.25−7.22 (m, 1H, Ar), 6.89 (dd, JHH = 8.8 and 7.6 Hz, 2H), 6.52
(t, JHH = 7.2 Hz, 1H, Ar), 6.41 (br. s, 1H, NH), 6.23 (dd, JHH = 8.8 and
1.2 Hz, 2H, Ar), 4.88, 4.69 (AB quartet, J = 13.2 Hz, 2H, NCH2N),
4.50 (s, 1H, PCHN), 4.46, 4.33 (AB quartet, J = 13.2 Hz, 2H,
NCH2N), 4.08, 3.56 (AB quartet, J = 13.6 Hz, 2H, NCH2N), 4.00 (td,
J = 14.0 and 1.8 Hz, 1H, PCH2N), 3.83−3.74 (m, 1H, PCH2N), 3.53
(t, J = 14.0 Hz, 1H, PCH2N), 3.43−3.35 (m, 1H, PCH2N). 13C{1H}
NMR (100 MHz, CDCl3): δ 145.5 (d, JPC = 1.5 Hz, Ar), 142.4 (d, JPC
= 2.3 Hz, Ar), 138.4 (s, Ar), 130.6 (d, JPC = 7.5 Hz, Ar), 129.1 (s, Ar),
128.5 (s, Ar), 128.2 (s, Ar), 128.1 (s, Ar), 127.8 (s, Ar), 127.3 (s, Ar),
MHz, CD3OD): δ −10.39 (s), −17.24 (s), −29.91 (s). ESI-MS
(positive, CH3OH): m/z = 566.76 for [(η6-C6H5CH3)RuCl(PTA-
CHPhNHPh)]+. HRMS (ESI, CH3OH) m/z calcd for
C26H31ClN4PRu: [M − Cl]+ 561.1051; found 561.1039.
Synthesis of [(η6-C6H5CH3)RuCl(κ2-(P,N)PTA-CH(p-
C6H4OCH3)NHPh)]Cl ([5]Cl). [(η6-C6H5CH3)RuCl(μ-Cl)]2 (136
mg, 0.26 mmol) and PTA-CH(p-C6H4OCH3)NHPh (190 mg, 0.52
mmol) were stirred in CH2Cl2 (20 mL) overnight, during which time a
homogeneous mixture formed. The solution was filtered through
Celite, and the solvent was removed under reduced pressure. The
residue was dissolved in minimum CH2Cl2 (∼10 mL), and hexane (80
mL) was added to precipitate the product. The precipitate was filtered
and washed with hexane (5 mL × 2) to give an orange solid (280 mg,
1
89% yield). H NMR (400 MHz, CD3OD): 7.72 (d, 1H, JHH = 8 Hz,
Ar), 7.60−7.48 (m, 1H, Ar), 7.42 (t, 1H, JHH = 8 Hz, Ar), 7.28−6.98
(m, 6H, Ar), 5.98−5.88 (m, 1H, C6H5CH3), 5.50 (t, 1H, JHH = 4.0 Hz,
C6H5CH3), 5.30−5.10 (m, 2H, C6H5CH3), 5.05 (d, 1H, J = 8 Hz,
C6H5CH3), 5.00−4.69 (m, 3H, NCH2N; 1H, PCHCHN; 3H,
PCH2N), 4.59 (d, 2H, J = 12 Hz, NCH2N), 4.43−4.27 (m, 1H,
PCHN; 1H, PCH2N), 4.22 (d, 1H, J = 12 Hz, NCH2N), 3.33 (s, 3H,
OCH3), 2.07 (s, 3H, C6H5CH3). 13C{1H} NMR (100 MHz, CD3OD):
δ 150.5 (s, Ar), 136.0 (d, JPC = 12 Hz, Ar), 130.6 (d, JPC = 12 Hz, Ar),
130.0 (s, Ar), 129.9 (s, Ar), 128.7 (s, Ar), 127.5 (s, Ar), 122.1 (s, Ar),
121.8 (s, Ar), 111.6 (d, JPC = 4.5 Hz, C6H5CH3), 99.9 (d, JPC = 9.0 Hz,
C6H5CH3), 94.6 (d, JPC = 2.2 Hz, C6H5CH3), 81.7 (s, C6H5CH3), 81.6
(s, C6H5CH3), 81.2 (s, C6H5CH3), 76.6 (d, JPC = 4.5 Hz, NCH2N),
74.0 (d, JPC = 7.5 Hz, NCH2N), 67.3 (d, JPC = 7.4 Hz, NCH2N), 66.8
(d, JPC = 8.1 Hz, PCHCHN), 65.6 (d, JPC = 21.7 Hz, PCHN), 52.9 (d,
JPC = 12.7 Hz, PCH2N), 52.1 (d, JPC = 14.3 Hz, PCH2N), 19.2 (s,
C6H5CH3). 31P{1H} NMR (162 MHz, CD3OD): δ −10.6 (s), −17.4
(s). ESI-MS (positive, CH3OH): m/z = 597.42 for [(η6-C6H5CH3)-
RuCl(PTA-CH(p-C6H4OCH3)NHPh)]+. HRMS (ESI, MeOH) m/z
calcd for C27H33ClN4OPRu: [M − Cl]+ 591.1157; found 591.1141.
Orange crystals suitable for X-ray diffraction were obtained as plates by
slow evaporation of a MeOH solution of the complex over the course
of a few days.
3
116.6 (s, Ar), 115.4 (s, Ar), 79.4 (s, NCH2N), 74.6 (d, JPC = 2.3 Hz,
1
2
NCH2N), 72.5 (d, JPC = 26.9 Hz, PCHN), 67.2 (d, JPC = 11.3 Hz,
CPh2NHPh), 66.2 (d, 3JPC = 3.0 Hz, NCH2N), 53.4 (d, 1JPC = 20.2 Hz,
PCH2N), 47.8 (d, 1JPC = 25.4 Hz, PCH2N). 31P{1H} NMR (162 MHz,
CDCl3): δ −97.7 (s). IR (KBr, cm−1): 3323 (sharp, υNH). HRMS (ESI,
CH3OH) m/z calcd for C25H27N4P: [M]+ 414.1973; found 414.1981.
Colorless crystals suitable for X-ray diffraction were obtained as blocks
by slow evaporation of a mixed CH2Cl2/CH3OH solution of 3 over
the course of a few days.
Synthesis of [(η6-C6H5CH3)RuCl(κ2-(P,N)PTA-CPh2NHPh)]Cl
([6]Cl). [(η6-C6H5CH3)RuCl(μ-Cl)]2 (137 mg, 0.25 mmol) and
PTA-CPh2NHPh (211 mg, 0.51 mmol) were stirred in CH2Cl2 (20
mL) overnight, during which time a homogeneous mixture formed.
The solution was filtered through Celite, and the solvent was removed
under reduced pressure. The residue was dissolved in minimum of
CH2Cl2 (∼10 mL), and hexane (80 mL) was added to precipitate the
product. The precipitate was filtered and washed with hexane (5 mL ×
Synthesis of the Oxides of 1−3 (1a−3a). The phosphine oxides
(1a−3a) were obtained quantitatively by the addition of 0.2 mmol
30% H2O2 to a 1 mL D2O solution of 1−3 (0.1 mmol). 31P{1H} NMR
(162 MHz, CDCl3): δ 1a, −2.9 (s), −5.7 (s); 2a, −2.9 (s), −5.7 (s);
3a, −1.5 (s).
Synthesis of [(η6-C6H5CH3)RuCl(κ2-(P,N)PTA-CHPhNHPh)]Cl
([4]Cl). [(η6-C6H5CH3)RuCl(μ-Cl)]2 (106 mg, 0.2 mmol) and PTA-
CHPhNHPh (137 mg, 0.4 mmol) were stirred in CH2Cl2 (20 mL)
overnight, during which time a homogeneous solution formed. The
solution was filtered through Celite and evaporated to dryness under
reduced pressure. The resulting residue was dissolved in minimum
CH2Cl2, and hexane was added until an orange precipitate was
observed. The solution was placed in the freezer for one hour, and the
precipitate was filtered, washed with hexane, and dried in vacuo to give
1
2) to give an orange solid (306 mg, 90% yield). H and 13C NMR
spectra were obtained at 55 °C due to the slightly broadening
spectrum observed at room temperature. 1H NMR (400 MHz,
CD3OD, 55 °C): δ 8.68 (d, 1H, JHH = 8.4 Hz, Ar), 7.86 (t, 1H, JHH
7.8 Hz, Ar), 7.61 (t, 2H, JHH = 7.4 Hz, Ar), 7.33−7.12 (m, 8H, Ar),
6.92 (m, 2H, Ar), 6.76 (d, 1H, JHH = 8.0 Hz, Ar), 6.40 (d, 1H, JHH
=
=
7.6 Hz, Ar), 6.14−6.08 (m, 1H, C6H5CH3), 6.00 (t, 1H, J = 5.2 Hz,
C6H5CH3), 5.60 (t, 1H, J = 5.6 Hz, C6H5CH3), 5.35 (d, 1H, J = 6.0
Hz, C6H5CH3), 5.10 (d, 1H, J = 6.0 Hz, C6H5CH3), 5.01 (d, J = 10.8
Hz, 1H, PCHN), 4.99 (d, J = 15.2 Hz, 1H, PCH2N), 4.82 (d, J = 13.2
Hz, 1H, NCH2N), 4.71−4.63 (m, 2H, PCH2N; 2H, NCH2N), 4.46 (d,
J = 13.2 Hz, 1H, NCH2N), 4.37 (d, J = 15.2 Hz, 1H, PCH2N), 3.88 (d,
J = 13.6 Hz, 1H, NCH2N), 2.54 (d, J = 14.0 Hz, 1H, NCH2N), 2.00 (s,
3H, C6H5CH3). 13C{1H} NMR (100 MHz, CD3OD): δ 150.8 (d, JPC
= 1.5 Hz, Ar), 139.0 (s, Ar), 139.0 (s, Ar), 137.8 (s, Ar), 134.5 (s, Ar),
131.5 (s, Ar), 131.0 (s, Ar), 130.8 (s, Ar), 130.5 (s, Ar), 130.4 (s, Ar),
130.4 (s, Ar), 129.5 (s, Ar), 128.6 (s, Ar), 125.0 (s, Ar), 124.2 (s, Ar),
113.5 (d, JPC = 5.9 Hz, C6H5CH3), 101.3 (d, JPC = 8.2 Hz, C6H5CH3),
93.6 (d, JPC = 1.5 Hz, C6H5CH3), 82.8 (s, C6H5CH3), 82.4 (s,
C6H5CH3), 82.0 (s, C6H5CH3), 79.0 (d, JPC = 1.9 Hz, NCH2N), 77.9
1
a yellow orange solid (206 mg, 85% yield). H NMR (400 MHz,
CD3OD): δ 7.72 (d, J = 7 Hz, 1H, Ar), 7.62 (d, J = 6 Hz, 1H, Ar), 7.45
(dd, J = 11 and 7 Hz, 1H, Ar), 7.29−7.04 (m, 6H, Ar), 7.04−6.95 (m,
1H, Ar), 5.93−5.84 (m, 1H, C6H5CH3), 5.50−5.41 (m, 1H,
C6H5CH3), 5.22 (d, J = 6 Hz, 1H, C6H5CH3), 5.20−5.11 (m, 1H,
PCH2N), 5.08 (d, J = 6 Hz, 1H, C6H5CH3), 5.05−4.95 (m, 1H,
PCHCHN), 4.84−4.75 (m, 2H PCH2N; 1H NCH2N), 4.76−4.71 (m,
1H, C6H5CH3), 4.69 (s, 1H, NCH2N), 4.66−4.57 (m, 2H, NCH2N),
4.38 (dd, J = 19, 11 Hz, 2H, NCH2N; 1H PCH2N), 4.24 (d, J = 10 Hz,
1H, PCHN), 2.08 (apparent doublet, J = 1 Hz, 3H, C6H5CH3). 13C
NMR (100 MHz, CD3OD): δ 149.08 (s, Ar), 134.60−134.47 (m, Ar),
134.43 (s, Ar), 129.36 (s, Ar), 129.17−129.07 (m, Ar), 128.59 (m, Ar),
127.25 (s, Ar), 126.17 (s, Ar), 98.38 (d, JPC = 8 Hz, C6H5CH3), 93.26
(d, JPC = 3.7 Hz, CPh2), 74.7 (d, JPC = 4.5 Hz, NCH2N), 67.3 (d, JPC
=
1744
dx.doi.org/10.1021/ic301160x | Inorg. Chem. 2013, 52, 1737−1746